Matthew Gline
CEO at Roivant Sciences Ltd.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Roivant Sciences Ltd., 3 years.
Roivant Sciences Ltd.
Director · CEO
Chief executive roles
Roivant Sciences Ltd.
· CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 20, 2024 | Roivant Sciences Ltd. | Shares withheld for tax | −10,945 | $11.57 | $126,634 |
| Nov 20, 2024 | Roivant Sciences Ltd. | Shares withheld for tax | −10,945 | $11.49 | $125,758 |
| Oct 20, 2024 | Roivant Sciences Ltd. | Shares withheld for tax | −10,945 | $11.92 | $130,464 |
| Sep 23, 2024 | Roivant Sciences Ltd. | Option exercise | +1,550,000 | $3.85 | $5,967,500 |
| Sep 23, 2024 | Roivant Sciences Ltd. | Open-market sale | −1,983,257 | $11.79 | $23,382,600 |
| Sep 23, 2024 | Roivant Sciences Ltd. | Other | −498,539 | $11.97 | $5,967,512 |
| Sep 20, 2024 | Roivant Sciences Ltd. | Shares withheld for tax | −10,945 | $11.97 | $131,012 |
| Aug 20, 2024 | Roivant Sciences Ltd. | Shares withheld for tax | −10,947 | $11.48 | $125,672 |
| Jul 26, 2024 | Roivant Sciences Ltd. | Grant or award | +2,754,821 | — | — |
| Jul 26, 2024 | Roivant Sciences Ltd. | Grant or award | +14,450,000 | — | — |
| Jul 20, 2024 | Roivant Sciences Ltd. | Shares withheld for tax | −10,945 | $11.00 | $120,395 |
| Jun 20, 2024 | Roivant Sciences Ltd. | Shares withheld for tax | −10,945 | $10.80 | $118,206 |
| May 20, 2024 | Roivant Sciences Ltd. | Shares withheld for tax | −10,945 | $11.37 | $124,445 |
| Apr 20, 2024 | Roivant Sciences Ltd. | Shares withheld for tax | −10,945 | $10.46 | $114,485 |
| Mar 30, 2024 | Roivant Sciences Ltd. | Option exercise | +390,579 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.